Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|June 1, 2017
Targeting PAR1: Now What?Robert Flaumenhaft, Karen De Ceunynck
Blood|October 25, 2012
Unwinding the von Willebrand factor strings puzzleKaren De Ceunynck, Simon F De Meyer, Karen Vanhoorelbeke
The Journal of Physical Chemistry. B|April 24, 2014
Shear-stress-induced conformational changes of von Willebrand factor in a water-glycerol mixture observed with single molecule microscopyRobrecht M A Vergauwe, Hiroshi Uji-i, Karen De Ceunynck, et al.
The Journal of Biological Chemistry|September 8, 2011
Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysisKaren De Ceunynck, Susana Rocha, Hendrik B Feys, et al.
The Journal of Biological Chemistry|February 20, 2014
Single particle tracking of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type-1 repeats) molecules on endothelial von Willebrand factor stringsKaren De Ceunynck, Susana Rocha, Simon F De Meyer, et al.
Blood|January 15, 2015
Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxarOmozuanvbo Aisiku, Christian G Peters, Karen De Ceunynck, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2018
PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injuryKaren De Ceunynck, Christian G Peters, Abhishek Jain, et al.
Blood|July 30, 2021
The secreted tyrosine kinase VLK is essential for normal platelet activation and thrombus formationLeila Revollo, Glenn Merrill-Skoloff, Karen De Ceunynck, et al.
The Journal of Clinical Investigation|January 24, 2018
Tie2 protects the vasculature against thrombus formation in systemic inflammationSarah J Higgins, Karen De Ceunynck, John A Kellum, et al.
Pageof 1